Galectin-1 as a potential cancer target.
Galectins are a family of structurally related carbohydrate-binding proteins, which are defined by their affinity for poly-N-acetyllactosamine-enriched glycoconjugates and sequence similarities in the carbohydrate recognition domain. Galectin-1, a member of this family, contributes to different events associated with cancer biology, including tumour transformation, cell cycle regulation, apoptosis, cell adhesion, migration and inflammation. In addition, recent evidence indicates that galectin-1 contributes to tumour evasion of immune responses. Given the increased interest of tumour biologists and clinical oncologists in this field and the potential use of galectins as novel targets for anticancer drugs, we summarise here recent advances about the role of galectin-1 in different events of tumour growth and metastasis.
Rabinovich
G A
GA
Division of Immunogenetics, Hospital de Clínicas "José de San Martín", University of Buenos Aires, Argentina. gabyrab@ciudad.com.ar
D017209:Apoptosis; D002448:Cell Adhesion; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic; D037483:Galectin 1 / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*
D037483:Galectin 1